Accendra Health (ACH) EBIT Growth (3y) (2012 - 2026)
Accendra Health (ACH) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 29.94% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 26.79% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -3.82% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 1.32% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 20.42% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.54% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 85.70% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 6.25% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.42% |
| Dec 31, 2025 | 19.44% |
| Sep 30, 2025 | -23.98% |
| Jun 30, 2025 | -36.24% |
| Mar 31, 2025 | -31.31% |
| Dec 31, 2024 | -85.63% |
| Sep 30, 2024 | -20.93% |
| Jun 30, 2024 | -44.10% |
| Mar 31, 2024 | -59.57% |
| Dec 31, 2023 | -2.45% |
| Sep 30, 2023 | -31.92% |
| Jun 30, 2023 | -21.25% |
| Mar 31, 2023 | -3.03% |
| Dec 31, 2022 | -78.40% |
| Sep 30, 2022 | 32.14% |
| Jun 30, 2022 | 67.78% |
| Mar 31, 2022 | 54.35% |
| Dec 31, 2021 | 31.51% |
| Sep 30, 2021 | 43.32% |
| Jun 30, 2021 | 36.85% |